The Mindfulness-Based Program for Depression and Anxiety: a pilot trial of an online interventio

Not Applicable

Completed

• Conditions: Major Depressive Disorder; Generalized Anxiety Disorder; Social Anxiety Disorder; Panic Disorder with or without Agoraphobia; Obsessive Compulsive Disorder; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12616000258459
• Lead Sponsor: St Vincent's Hospital Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

* Self-identified as suffering from depression and/or anxiety.
* Meet criteria for either Major Depressive Disprder (MDD), Generalized Anxiety Disorder (GAD), Social Phobia (SP), Panic Disorder (PD), Agoraphobia (AG), or Obsessive-Compulsive Disorder (OCD) according to the Mini International Neuropsychiatric Interview Version 5.0.0 (MINI)
* Australian resident status
* At least 18 years of age
* Access to a computer, printer, and the internet
* If taking medication, must have been taking the same dose for at least 1 month and not intend to change that dose during the course of the program.
* Prepared to provide name, phone number, and address, and to provide the name and phone number of a local general practitioner.
* Willing to provide informed consent.

Exclusion Criteria

- Does not meet diagnostic criteria for an anxiety or depressive disorder.
- Currently experiencing severe depression symptoms (score of 23 or above on the PHQ-9).
- Regularly using illicit drugs or regularly consuming more than three standard drinks per day
- Current regular use of benzodiazepines
- Current use of atypical anti-psychotics
- Currently experiencing a psychotic mental illness or bipolar disorder
- Completed an online program for depresison and/or anxiety in the past year
- Severe symptoms of suicidal ideation (defined as responding 3 to the PHQ-9 question 9 item that assesses the frequency of suicidal ideation over the past fortnight).
-Those scoring 1 or 2 on the Patient Health Questionnaire_9 Item (PHQ-9) item 9 will require risk assessment with the responsible clinician before being admitted into the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in depression symptoms (according to mean scores on the Patient Health Questionnaire (PHQ-9) [Baseline, mid-treatment (before Lesson 5), one week post-treatment - either one week after the participant has completed the 7 lessons (as they may have completed one lesson per week of the program) or one week after the 14 weeks, and at 3-month post-treatment (week 24)];Changes in anxiety symptoms according to mean scores on the Generalised Anxiety Disorder 7-item scale (GAD-7).[Baseline, mid-treatment (before Lesson 5), one week post-treatment - either one week after the participant has completed the 7 lessons (as they may have completed one lesson per week of the program) or one week after the 14 weeks, and at 3-month post-treatment (week 24)]